Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Texto
Imagem
Documentos relacionados
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung
The model validation was performed comparing the results of modal numerical analysis with the in situ measurements, for which a set of dynamic tests was carried out in order
Nesse am- biente, o zinco é também fixado pelos fosfatos (Vino- graclov 1959). A mobilidade do zinco não é função apenas do p11. Do mesmo modo que para os outros elementos me- nores,
To analyze and describe a series of patients with non- small cell lung cancer treated with erlotinib during a period prior to the mandatory investigation of the epidermal
The aim of this study was to evaluate the frequency of epidermal growth factor receptor and KRAS mutations in a population of Brazilian patients with non-small cell lung
Do conjunto de críticos vindos das gerações anteriores, Fernando Pernes, ainda que nunca se debruçando em concreto sobre o trabalho de Sarmento destes anos nos textos
Objective regression in non-small cell lung cancer patients treated in phase I trials of oral ZD 1839 (Iressa), a selective tyrosine kinase inhibitor that blocks the epidermal
Neste sentido foi proposto um modelo que permitisse explicitar esta relação, bem como identificar e explicar a forma como a qualidade de vida e a comunicação da marca